GlycoMimetics, Inc. (GLYC) DCF Valuation

GlycoMimetics, Inc. (GLYC) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

GlycoMimetics, Inc. (GLYC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore GlycoMimetics, Inc. (GLYC) financial prospects with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to calculate GlycoMimetics, Inc. (GLYC) intrinsic value and enhance your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 10.2 1.2 .1 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 -88.59 -93.54 -86.65 -67.2 -67.2 -67.2 -67.2 -67.2
EBITDA -57.0 -51.2 -63.2 -47.2 -39.1 .0 .0 .0 .0 .0
EBITDA, % 100 -504.17 -5446.78 -62991.23 -391219.92 -60 -60 -60 -60 -60
Depreciation .9 1.0 1.0 1.0 .2 .0 .0 .0 .0 .0
Depreciation, % 100 9.36 87.38 1377.59 1533.01 79.35 79.35 79.35 79.35 79.35
EBIT -57.9 -52.2 -64.2 -48.2 -39.3 .0 .0 .0 .0 .0
EBIT, % 100 -513.53 -5534.16 -64368.81 -392752.93 -60 -60 -60 -60 -60
Total Cash 158.2 137.0 90.3 47.9 41.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .1 .4 .0 .0 .0 .0 .0
Account Receivables .2 .0 .0 .1 .2
Account Receivables, % 100 0.02114533 0.11612 192.21 1758.2
Inventories -4,322.2 -1,237.1 -533.8 -.1 .0 .0 .0 .0 .0 .0
Inventories, % 100 -12172.51 -46017.7 -192.72 0 -40 -40 -40 -40 -40
Accounts Payable 1.4 2.1 2.1 1.0 .9 .0 .0 .0 .0 .0
Accounts Payable, % 100 20.56 181.69 1294.88 8681.15 84.11 84.11 84.11 84.11 84.11
Capital Expenditure -.1 -.1 .0 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 -0.67408 -1.29 -112.37 -213.94 -40.39 -40.39 -40.39 -40.39 -40.39
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -54.1 -51.4 -63.9 -96.4 -39.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 4,270.1 -3,134.8 -766.2 -630.4 -39.4 -.7 .0 .0 .0 .0
WACC, % 12.68 12.7 12.7 12.7 12.7 12.7 12.7 12.7 12.7 12.7
PV UFCF
SUM PV UFCF -.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -41
Equity Value 40
Diluted Shares Outstanding, MM 63
Equity Value Per Share 0.64

What You Will Get

  • Real GlycoMimetics Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on GlycoMimetics’ fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for GlycoMimetics, Inc. (GLYC).
  • WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to GLYC.
  • Customizable Forecast Assumptions: Adjust growth projections, capital expenditures, and discount rates for accurate modeling.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to GlycoMimetics, Inc. (GLYC).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.

How It Works

  • 1. Access the Template: Download and open the Excel file containing GlycoMimetics, Inc.'s (GLYC) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate multiple forecasts to assess various valuation possibilities.
  • 5. Present with Assurance: Deliver professional valuation insights to substantiate your strategic decisions.

Why Choose This Calculator?

  • User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your financial analysis.
  • Real-Time Feedback: Observe immediate updates to GlycoMimetics, Inc.'s (GLYC) valuation as you modify inputs.
  • Preloaded Data: Comes equipped with GlycoMimetics, Inc.'s (GLYC) latest financial information for swift evaluations.
  • Relied Upon by Experts: A go-to tool for investors and analysts seeking to make well-informed choices.

Who Should Use This Product?

  • Investors: Accurately assess GlycoMimetics, Inc.'s (GLYC) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to GlycoMimetics, Inc. (GLYC).
  • Consultants: Efficiently customize the template for valuation reports tailored to GlycoMimetics, Inc. (GLYC) clients.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech companies.
  • Educators: Implement it as a teaching resource to illustrate valuation techniques relevant to GlycoMimetics, Inc. (GLYC).

What the Template Contains

  • Pre-Filled Data: Contains GlycoMimetics’ historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model featuring automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC using custom inputs.
  • Key Financial Ratios: Evaluate GlycoMimetics’ profitability, efficiency, and leverage.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing essential valuation results.

No products were found matching.